Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital, Nagoya, Aichi, Japan.
Bone Marrow Transplant. 2004 Jun;33(11):1143-50. doi: 10.1038/sj.bmt.1704512.
Thrombotic microangiopathy after bone marrow transplantation (post-BMT TMA) is a serious transplant-related complication. We identified 16 patients with TMA after allogeneic BMT who showed histopathological evidence of intestinal TMA in their gut specimens (six autopsies, 10 biopsies). In all, 14 patients had grade II-IV acute graft-versus-host disease (GVHD). The first seven patients were retrospectively diagnosed with TMA. Since six of them were diagnosed with progressive GVHD at that time because there was no awareness of the existence of intestinal TMA, they received more intensive treatment for GVHD, but all died between days +49 and +253. In contrast, the remaining nine patients were recently diagnosed with intestinal TMA on the basis of colonoscopic biopsies. For eight of these patients, the immunosuppressants were reduced, and the patients' intestinal symptoms improved gradually. Six of the nine patients were still alive 12 months after the diagnosis of TMA. Our findings suggest that the gut may be a site involved in post-BMT TMA, presenting as ischemic enterocolitis. Differentiating intestinal TMA from acute GVHD is important in patients suffering from severe and refractory diarrhea after BMT.
骨髓移植后血栓性微血管病(BMT后TMA)是一种严重的移植相关并发症。我们确定了16例异基因BMT后发生TMA的患者,他们的肠道标本显示有肠道TMA的组织病理学证据(6例尸检,10例活检)。总共14例患者患有II-IV级急性移植物抗宿主病(GVHD)。前7例患者是回顾性诊断为TMA。由于当时其中6例被诊断为进行性GVHD,因为没有意识到肠道TMA的存在,他们接受了更强化的GVHD治疗,但均在+49天至+253天之间死亡。相比之下,其余9例患者最近根据结肠镜活检诊断为肠道TMA。其中8例患者减少了免疫抑制剂用量,患者的肠道症状逐渐改善。9例患者中有6例在诊断TMA后12个月仍存活。我们的研究结果表明,肠道可能是BMT后TMA涉及的部位,表现为缺血性小肠结肠炎。在BMT后患有严重和难治性腹泻的患者中,区分肠道TMA与急性GVHD很重要。